AFFiRiS AG
Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you.
Anelixis Therapeutics
Advancing impactful treatments to help patients combat the progression of neurodegenerative diseases.
Side-by-Side Comparison
| Metric | AFFiRiS AG | Anelixis Therapeutics |
|---|---|---|
| Founded | 2003 | 2012 |
| Headquarters | Wien, Austria | Not tracked yet |
| Employees | 2 | Not tracked yet |
| Industry | Biotechnology, Pharmaceutical | Biotechnology |
| Funding Stage | Unknown | Series Unknown |
| Total Funding | $47.00M | $6.86M |
| Funding Rounds | 4 | 2 |
| Business Model | Not tracked yet | Not tracked yet |
| Revenue Model | Not tracked yet | Not tracked yet |
| Services | Not tracked yet | Not tracked yet |
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | Immunotherapy, Neurodegenerative Diseases, Parkinson's Disease, Alzheimer's Disease, Multiple System Atrophy, Dementia With Lewy Bodies, Huntington's Disease, Clinical-stage Biotechnology, SAIT, AFFITOME Technology, Peptide Vaccines, Vienna, Austria, Clinical Trials, Monoclonal Antibody | Anelixis Therapeutics, Cambridge, Massachusetts, Neurodegenerative Diseases, Clinical-stage Therapies, Immune Modulatory Drugs, Amyotrophic Lateral Sclerosis, ALS, Alzheimer's Disease, Patient-focused Treatments, Life-improving Therapies, Clinical Stage Development, Biopharmaceutical Company, Disease Progression, Treatment Advancement |
| Website | affiris.com | anelixistherapeutics.com |
About AFFiRiS AG
AFFiRiS AG is a clinical-stage biotechnology company based in Austria, founded in 2003. The company's slogan, "Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you," encapsulates their mission to challenge established treatment options for neurode...
About Anelixis Therapeutics
Anelixis Therapeutics, based in Cambridge, Massachusetts, is a biotechnology company specializing in the development of clinical-stage therapies focused on immune modulatory drugs for neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) and Alzheimer's Disease (AD). Founded i...
Frequently Asked Questions
Track both companies in real time
Signal Tracker monitors AFFiRiS AG, Anelixis Therapeutics, and millions of companies for 40+ signal types.